
Jack Lapides M.D. Research Professor
Professor of Urology and Section Head
Urologic Oncology
Medical School
[email protected]
Available to mentor
Todd Morgan

Professor
-
Urologic Oncology FellowshipVanderbilt University Medical Center, Urology, 2011
-
Urology ResidencyUniversity of Washington Medical Center, Urology, 2009
-
General Surgery InternshipUniversity of Washington Medical Center, Urology, 2004
-
Center MemberTaubman Institute
-
Center MemberRogel Cancer Center
-
Krischak M, Bank M, Elliot D, Landis-Lewis Z, Lewicki P, Piatt G, Morgan T, Barnes G, Bryant A, Caram M, Tsao P, Harrod M, Skolarus T, Sales A, Stensland K. Journal of Urology, 2025 Apr 10; 213 (5S): e212Journal ArticleIP04-10 ARE VETERANS WITH PROSTATE CANCER SCIENTIFICALLY UNDERSERVED? DESCRIBING ACCESS TO PROSTATE CANCER CLINICAL TRIALS IN THE VA
DOI:10.1097/01.ju.0001109780.20015.87.10 -
Monda S, Vaishampayan U, Kaffenberger S, Triner D, Nallandhighal S, Morgan T, Hafez K, Knuth Z, Singhal U, Gulati S, Palapattu G, Salami S. Journal of Urology, 2025 Apr 10; 213 (5S): e877Journal ArticleIP16-30 DO TISSUE-BASED BIOMARKERS IN METASTATIC CLEAR CELL RENAL CELL CARCINOMA PERFORM BETTER WHEN DERIVED FROM A METASTATIC SITE COMPARED TO THE PRIMARY?
DOI:10.1097/01.ju.0001110024.72300.75.30 -
Moser AM, Elanjian A, Meah S, Labardee C, Lane BR, Dabaja A, Burks F, Morgan T, Sessine M, Borza T, Ginsburg KB, Collaborative FTMUSI. Journal of Urology, 2025 Apr 10; 213 (5S): e688Journal ArticleMP19-15 RISK OF CLINICALLY SIGNIFICANT PROSTATE CANCER ON SUBSEQUENT BIOPSIES IN MEN WITH MULTIFOCAL HIGH GRADE PROSTATIC INTRAEPITHELIAL NEOPLASIA OR ATYPICAL SMALL ACINAR PROLIFERATION ON MRI-INFORMED INDEX BIOPSY
DOI:10.1097/01.ju.0001109948.41896.8a.15 -
Monda S, Demus T, Meah S, Srivastava A, Sarle R, Ginsburg K, Morgan T, Borza T, Collaborative FTMUSI. Journal of Urology, 2025 Apr 10; 213 (5S): e781Journal ArticleMP22-01 DECLINE IN THE SURGICAL OVERTREATMENT OF PROSTATE CANCER
DOI:10.1097/01.ju.0001109988.34650.0d.01 -
Monda S, Nallandhighal S, Vaishampayan U, Singhal U, Knuth Z, Mehra R, Kaffenberger S, Hafez K, Udager A, Palapattu G, Morgan T, Salami S. Journal of Urology, 2025 Apr 10; 213 (5S): e1004Journal ArticleMP28-03 VALIDATION OF A 15-GENE PROGNOSTIC SIGNATURE IN METASTATIC CLEAR CELL RENAL CELL CARCINOMA
DOI:10.1097/01.ju.0001110068.14710.ff.03 -
Nallandhighal S, Mannan R, Mahapatra S, Knuth Z, Singhal U, Mehra R, Morgan T, Salami S, Spalapattu G, Zaslavsky A. Journal of Urology, 2025 Apr 10; 213 (5S): e374Journal ArticlePD10-05 NARROW RANGE MOLECULAR INFLUENCE OF PROSTATE TUMORS ON SURROUNDING TISSUE REVEALED BY SPATIAL GENOMICS
DOI:10.1097/01.ju.0001109840.15154.ea.05 -
Solorzano MA, Abusamra SM, Quarles J, Luke M, Patel M, Vince R, Jiang R, Volin J, Jacobs MF, Kaffenberger S, Salami SS, Palmbos P, Caram MEV, Palapattu GS, Hollenbeck BK, Merajver SD, Stoffel EM, Hafron J, Morgan TM, Reichert ZR. Journal of Urology, 2025 Apr 10; 213 (5S): e375Journal ArticlePD10-06 DETECTION OF GERMLINE VARIANTS IN PATIENTS WITH LOCALIZED AND METASTATIC PROSTATE CANCER THROUGH GUIDELINE-BASED TESTING
DOI:10.1097/01.ju.0001109840.15154.ea.06 -
Armstrong AJ, Liu VYT, Selvaraju RR, Chen E, Simko JP, DeVries S, Sartor O, Sandler HM, Mohamad O, Huang H-C, Griffin J, Yamashita R, Esteva A, Tran PT, Spratt DE, Carson JH, Peters C, Gore E, Lee SP, Monson JM, Augspurger ME, El-Gayed A, Rodgers JP, McKay R, Morgan T, Feng FY, Nguyen PL. J Clin Oncol, 2025 Apr 16; JCO2400365Journal ArticleDevelopment and Validation of an Artificial Intelligence Digital Pathology Biomarker to Predict Benefit of Long-Term Hormonal Therapy and Radiotherapy in Men With High-Risk Prostate Cancer Across Multiple Phase III Trials.
DOI:10.1200/JCO.24.00365 PMID: 40239134

Health Lab
Just 8 months after undergoing robotic surgery to remove his cancerous prostate, Mark Cwiek, a 70-year-old track and field athlete, successfully competed in the World Masters Athletics Championship.
Department News
Todd Morgan, Professor of Urology, discussed his SUO fellowship experience on BackTable Urology.
Department News
The Weiser Center for Prostate Cancer celebrated its programs, patient advocates, and all the prostate care team members across multiple departments and care team roles.